Literature DB >> 2825342

Lucigenin-dependent chemiluminescence in mononuclear phagocytes. Role of superoxide anion.

T B Aasen1, B Bolann, J Glette, R J Ulvik, A Schreiner.   

Abstract

A method for the measurement of reactive oxygen species generated by activated mononuclear phagocytes by use of lucigenin-dependent chemiluminescence was developed. Opsonized zymosan was used as a stimulant to evaluate the chemiluminescence response of monocytes. A cell-free system in which superoxide anion and hydrogen peroxide were produced by the xanthine-xanthine oxidase reaction was used to examine the role of these radical species in the excitation of lucigenin, and to standardize the chemiluminescence method. It was found that the light emission in lucigenin-dependent chemiluminescence was evoked by the superoxide anion, but other radicals may also be active.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825342

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages.

Authors:  Susu M Zughaier; William M Shafer; David S Stephens
Journal:  Cell Microbiol       Date:  2005-09       Impact factor: 3.715

2.  Effect of immunoglobulins on mineral dust-induced production of reactive oxygen metabolites by human macrophages.

Authors:  P Nyberg; M Klockars
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

3.  Measurement of reactive oxygen metabolites produced by human monocyte-derived macrophages exposed to mineral dusts.

Authors:  P Nyberg; M Klockars
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

4.  N-chlorination mediates protective and immunomodulatory effects of oxidized human plasma proteins.

Authors:  Agnes Ulfig; Anton V Schulz; Alexandra Müller; Natalie Lupilov; Lars I Leichert
Journal:  Elife       Date:  2019-07-12       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.